Subject: Statistical methodology | Medicine, Research & Experimental | Rare disease | SIMULATION | Life Sciences & Biomedicine | Medicine | Research & Experimental Medicine | Small population clinical trials | Science & Technology | MIXED-EFFECTS MODELS | Genetics & Heredity | DISTRIBUTIONS | RESEARCH-AND-DEVELOPMENT | SELECTION BIAS | R | TEST DECISIONS | Statistical design | Review | PARAMETER UNCERTAINTY | ADAPTIVE DESIGNS | DRUG RESEARCH | Statistical analysis | REGRESSION-MODELS
BACKGROUND: IDeAl (Integrated designs and analysis of small population clinical trials) is an EU funded project developing new statistical design and analysis methodologies for clinical trials in small population groups. Here we provide an overview of IDeAl findings and... View more
Miller, F, Burman, CF. A decision theoretical modeling for phase III investments and drug licensing. J Biopharm Stat. 2017; 18: 1-24
Ondra, T. Optimizing trial designs for targeted therapies. PLoS One. 2017; 11 (9): e0163726
10.Burman CF. From optimal design theory to optimizing designs of clinical trials. [book auth.] E. Fackle-Fornius. Festschrift in honor of Hans Nyquist on the occasion of his 65th birthday. Stockholm: Stockholm Univ 2015.